Sana Intidhar Labidi-Galy

10PUBLICATIONS
55CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursGenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 06, 2026
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.

Hiba Mechahougui, Léna Royston, Catia Vieira Gomes

|Jul 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.

Olivia Le Saux, Maude Ardin, Justine Berthet

|May 24, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.

Diego Dibitetto, Martin Liptay, Francesca Vivalda

|Dec 19, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.

Judith Balmaña, Peter A Fasching, Fergus J Couch

|Nov 09, 2023
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor.

José L Sandoval, S Intidhar Labidi-Galy

|Jun 12, 2023
Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics.

Lou Romanens, Prasad Chaskar, Rachel Marcone

Pageof 2

Frequent Collaborators

1 joint publications

Judith Balmaña

1 joint publications

Peter A Fasching

1 joint publications

Fergus J Couch

1 joint publications

Suzette Delaloge